Flavia Serafini

Papers

Total Citations

H-Index

About

Flavia Serafini is a leading figure in radiation oncology, whose work has significantly advanced the precision and efficacy of stereotactic radiotherapy for recurrent cancers. Her research centers on image-guided radiation therapy (IGRT) and stereotactic body radiotherapy (SBRT), particularly for challenging cases like isolated lymph node recurrences in prostate cancer. Serafini’s landmark 2009 study, which has garnered 71 citations, provided critical comparative data on linac-based versus robotic SBRT approaches, demonstrating that both modalities offer high local control with minimal toxicity. This work helped establish SBRT as a viable, non-invasive salvage option, directly influencing clinical guidelines and sparing patients from more aggressive treatments. Beyond this, her contributions have shaped protocols for tumor motion management and dose escalation, improving treatment accuracy across multiple cancer sites. With a citation record reflecting her impact on both clinical practice and technological innovation, Serafini is recognized for bridging the gap between advanced radiotherapy physics and patient-centered outcomes, making her a key voice in the evolution of modern, targeted cancer care.